The DOI matches its Crossref record; 89 of the 89 references it cites were found in a registry or an index.
Tumor resistance to apoptosis
Open accessAbstract
One of the hallmarks of human cancers is the intrinsic or acquired resistance to apoptosis. Evasion of apoptosis may contribute to carcinogenesis, tumor progression and also to treatment resistance, since most current anticancer therapies including chemotherapy, radio‐ and immunotherapy primarily act by activating cell death pathways including apoptosis in cancer cells. Hence, a better understanding of the molecular mechanisms underlying tumor resistance to apoptotic cell death is expected to provide the basis for a rational approach to develop molecular targeted therapies. © 2008 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Akt Phosphorylation and Stabilization of X-linked Inhibitor of Apoptosis Protein (XIAP)
Dan, H. C., Sun, M., Kaneko, S., Feldman, R. I., Nicosia, S. V., Wang, H.-G., Tsang, B. K., & Cheng, J. Q. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m312044200 · Cited by 422
RetractedHengartner, M. O. (2000) · Nature · doi:10.1038/35037710 · Cited by 5,779
Mitochondrial membrane permeabilization in cell death
Kroemer, G., Galluzzi, L., & Brenner, C. (2007) · Physiological Reviews · doi:10.1152/physrev.00013.2006 · Cited by 3,598
Du, C., Fang, M., Li, Y., Li, L., & Wang, X. (2000) · Cell · doi:10.1016/s0092-8674(00)00008-8 · Cited by 3,513
Proliferation, cell cycle and apoptosis in cancer
Evan, G. I., & Vousden, K. H. (2001) · Nature · doi:10.1038/35077213 · Cited by 2,724
Kischkel, F. C., Hellbardt, S., Behrmann, I., Germer, M., Pawlita, M., Krammer, P. H., & Peter, M. E. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb00245.x · Cited by 2,184
The Bcl-2 apoptotic switch in cancer development and therapy
Adams, J. M., & Cory, S. (2007) · Oncogene · doi:10.1038/sj.onc.1210220 · Cited by 2,176
Lowe, S. W., & Lin, A. W. (2000) · Carcinogenesis · doi:10.1093/carcin/21.3.485 · Cited by 1,876
Chen, L., Willis, S. N., Wei, A., Smith, B. J., Fletcher, J. I., Hinds, M. G., Colman, P. M., Day, C. L., Adams, J. M., & Huang, D. C. S. (2005) · Molecular Cell · doi:10.1016/j.molcel.2004.12.030 · Cited by 1,816
Tsujimoto, Y., Finger, L. R., Yunis, J., Nowell, P. C., & Croce, C. M. (1984) · Science · doi:10.1126/science.6093263 · Cited by 1,769
Letai, A., Bassik, M. C., Walensky, L. D., Sorcinelli, M. D., Weiler, S., & Korsmeyer, S. J. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00127-7 · Cited by 1,677
The role of autophagy in cancer development and response to therapy
Kondo, Y., Kanzawa, T., Sawaya, R., & Kondo, S. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1692 · Cited by 1,654
The JNK signal transduction pathway
Weston, C. (2002) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(01)00258-1 · Cited by 1,528
DNA damage-induced cell death by apoptosis
Roos, W. P., & Kaina, B. (2006) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2006.07.007 · Cited by 1,500
Rampino, N., Yamamoto, H., Ionov, Y., Li, Y., Sawai, H., Reed, J. C., & Perucho, M. (1997) · Science · doi:10.1126/science.275.5302.967 · Cited by 1,326
Apoptosis Initiated When BH3 Ligands Engage Multiple Bcl-2 Homologs, Not Bax or Bak
Willis, S. N., Fletcher, J. I., Kaufmann, T., van Delft, M. F., Chen, L., Czabotar, P. E., Ierino, H., Lee, E. F., Fairlie, W. D., Bouillet, P., et al. (2007) · Science · doi:10.1126/science.1133289 · Cited by 1,125
Degterev, A., Boyce, M., & Yuan, J. (2003) · Oncogene · doi:10.1038/sj.onc.1207107 · Cited by 1,107
Pathways of apoptotic and non-apoptotic death in tumour cells
Okada, H., & Mak, T. W. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1412 · Cited by 1,044
The JNK signal transduction pathway
Weston, C. R., & Davis, R. J. (2007) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2007.02.001 · Cited by 1,021
Survivin, cancer networks and pathway-directed drug discovery
Altieri, D. C. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2293 · Cited by 994
Inactivation of the apoptosis effector Apaf-1 in malignant melanoma
Soengas, M. S., Capodieci, P., Polsky, D., Mora, J., Esteller, M., Opitz-Araya, X., McCombie, R., Herman, J. G., Gerald, W. L., Lazebnik, Y. A., et al. (2001) · Nature · doi:10.1038/35051606 · Cited by 966
McDonnell, T. J., & Korsmeyer, S. J. (1991) · Nature · doi:10.1038/349254a0 · Cited by 858
Human inhibitor of apoptosis proteins: why XIAP is the black sheep of the family
Eckelman, B. P., Salvesen, G. S., & Scott, F. L. (2006) · The EMBO Reports · doi:10.1038/sj.embor.7400795 · Cited by 813
Teitz, T., Wei, T., Valentine, M. B., Vanin, E. F., Grenet, J., Valentine, V. A., Behm, F. G., Look, A. T., Lahti, J. M., & Kidd, V. J. (2000) · Nature Medicine · doi:10.1038/75007 · Cited by 811
Genomic amplification of a decoy receptor for Fas ligand in lung and colon cancer
Pitti, R. M., Marsters, S. A., Lawrence, D. A., Roy, M., Kischkel, F. C., Dowd, P., Huang, A., Donahue, C. J., Sherwood, S. W., Baldwin, D. T., et al. (1998) · Nature · doi:10.1038/25387 · Cited by 783
Analysis of human transcriptomes
Velculescu, V. E., Madden, S. L., Zhang, L., Lash, A. E., Yu, J., Rago, C., Lal, A., Wang, C. J., Beaudry, G. A., Ciriello, K. M., et al. (1999) · Nature Genetics · doi:10.1038/70487 · Cited by 774
Dierlamm, J., Baens, M., Wlodarska, I., Stefanova-Ouzounova, M., Hernandez, J. M., Hossfeld, D. K., De Wolf-Peeters, C., Hagemeijer, A., Van den Berghe, H., & Marynen, P. (1999) · Blood · doi:10.1182/blood.v93.11.3601 · Cited by 718
Expression and prognostic significance of IAP-family genes in human cancers and myeloid leukemias.
Tamm, I., Kornblau, S. M., Segall, H., Krajewski, S., Welsh, K., Kitada, S., Scudiero, D. A., Tudor, G., Qui, Y. H., Monks, A. P., et al. (2000) · PubMed · Cited by 620
IAPs, RINGs and ubiquitylation
Vaux, D. L., & Silke, J. (2005) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1621 · Cited by 610
The inhibitors of apoptosis (IAPs) as cancer targets
Hunter, A. M., LaCasse, E. C., & Korneluk, R. G. (2007) · Apoptosis · doi:10.1007/s10495-007-0087-3 · Cited by 565
Lavrik, I., Golks, A., & Krammer, P. H. (2005) · Journal of Cell Science · doi:10.1242/jcs.01610 · Cited by 494
Good cop, bad cop: the different faces of NF-κB
Perkins, N. D., & Gilmore, T. D. (2006) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401838 · Cited by 489
Bim is a suppressor of Myc-induced mouse B cell leukemia
Egle, A., Harris, A. W., Bouillet, P., & Cory, S. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0401471101 · Cited by 488
Identification of XAF1 as an antagonist of XIAP anti-Caspase activity
Liston, P., Fong, W. G., Kelly, N. L., Toji, S., Miyazaki, T., Conte, D., Tamai, K., Craig, C. G., McBurney, M. W., & Korneluk, R. G. (2001) · Nature Cell Biology · doi:10.1038/35055027 · Cited by 441
Targeting the extrinsic apoptosis pathway in cancer
Ashkenazi, A. (2008) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2008.04.001 · Cited by 418
Anti-apoptosis gene, survivin, and prognosis of neuroblastoma
Adida, C., Berrebi, D., Peuchmaur, M., Reyes-Mugica, M., & Altieri, D. C. (1998) · The Lancet · doi:10.1016/s0140-6736(05)70294-4 · Cited by 415
Fulda, S., Küfer, M. U., Meyer, E., van Valen, F., Dockhorn-Dworniczak, B., & Debatin, K.-M. (2001) · Oncogene · doi:10.1038/sj.onc.1204750 · Cited by 404
Self-citationIslam, A., Kageyama, H., Takada, N., Kawamato, T., Takayasu, H., Isogai, E., Ohira, M., Hashizume, K., Kobayashi, H., Kaneko, Y., et al. (2000) · Oncogene · doi:10.1038/sj.onc.1203358 · Cited by 386
Grønbæk, K., Straten, P. T., Ralfkiaer, E., Ahrenkiel, V., Andersen, M. K., Hansen, N. E., Zeuthen, J., Hou-Jensen, K., & Guldberg, P. (1998) · Blood · doi:10.1182/blood.v92.9.3018 · Cited by 336
A CASP-8 Mutation Recognized by Cytolytic T Lymphocytes on a Human Head and Neck Carcinoma
Mandruzzato, S., Brasseur, F., Andry, G., Boon, T., & Bruggen, P. V. D. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.5.785 · Cited by 321
Tagawa, H., Karnan, S., Suzuki, R., Matsuo, K., Zhang, X., Ota, A., Morishima, Y., Nakamura, S., & Seto, M. (2005) · Oncogene · doi:10.1038/sj.onc.1208300 · Cited by 307
XIAP Induces NF-κB Activation via the BIR1/TAB1 Interaction and BIR1 Dimerization
Lu, M., Lin, S.-C., Huang, Y., Kang, Y. J., Rich, R., Lo, Y.-C., Myszka, D., Han, J., & Wu, H. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.05.006 · Cited by 290
Hopkins-Donaldson, S., Ziegler, A., Kurtz, S., Bigosch, C., Kandioler, D., Ludwig, C., Zangemeister-Wittke, U., & Stahel, R. (2003) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401157 · Cited by 270
Emi, M., Fujiwara, Y., Nakajima, T., Tsuchiya, E., Tsuda, H., Hirohashi, S., Maeda, Y., Tsuruta, K., Miyaki, M., & Nakamura, Y. (1992) · PubMed · Cited by 268
Pepper, C., Lin, T. T., Pratt, G., Hewamana, S., Brennan, P., Hiller, L., Hills, R., Ward, R., Starczynski, J., Austen, B., et al. (2008) · Blood · doi:10.1182/blood-2008-05-157131 · Cited by 248
Homozygous deletions localize novel tumor suppressor genes in B-cell lymphomas
Mestre-Escorihuela, C., Rubio-Moscardo, F., Richter, J. A., Siebert, R., Climent, J., Fresquet, V., Beltran, E., Agirre, X., Marugan, I., Marín, M., et al. (2007) · Blood · doi:10.1182/blood-2006-06-026500 · Cited by 246
Mutations in the Fas Antigen in Patients With Multiple Myeloma
Landowski, T. H., Qu, N., Buyuksal, I., Painter, J. S., & Dalton, W. S. (1997) · Blood · doi:10.1182/blood.v90.11.4266 · Cited by 244
Alterations of Fas (Apo-1/CD95) gene in non-small cell lung cancer
Lee, S. H., Shin, M. S., Park, W. S., Kim, S. Y., Kim, H. S., Han, J. Y., Park, G. S., Dong, S. M., Pi, J. H., Kim, C. S., et al. (1999) · Oncogene · doi:10.1038/sj.onc.1202769 · Cited by 238
Jin, Z., McDonald, E. R., Dicker, D. T., & El-Deiry, W. S. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m405538200 · Cited by 237
Caspases, IAPs and Smac/DIABLO: mechanisms from structural biology
Shiozaki, E. N., & Shi, Y. (2004) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2004.07.003 · Cited by 235
Hofer-Warbinek, R., Schmid, J. A., Stehlik, C., Binder, B. R., Lipp, J., & de Martin, R. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m910346199 · Cited by 231
Inactivating mutations of caspase-8 gene in colorectal carcinomas
Kim, H. S., Lee, J. W., Soung, Y. H., Park, W. S., Kim, S. Y., Lee, J. H., Park, J. Y., Cho, Y. G., Kim, C. J., Jeong, S. W., et al. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)01059-x · Cited by 229
Deficient activation of the CD95 (APO-1/Fas) system in drug-resistant cells
Friesen, C., Fulda, S., & Debatin, K.-M. (1997) · Leukemia · doi:10.1038/sj.leu.2400827 · Cited by 207
Self-citationSrc kinase phosphorylates Caspase‐8 on Tyr380: a novel mechanism of apoptosis suppression
Cursi, S., Rufini, A., Stagni, V., Condò, I., Matafora, V., Bachi, A., Bonifazi, A. P., Coppola, L., Superti‐Furga, G., Testi, R., et al. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601085 · Cited by 205
Roth, W., Isenmann, S., Nakamura, M., Platten, M., Wick, W., Kleihues, P., Bähr, M., Ohgaki, H., Ashkenazi, A., & Weller, M. (2001) · PubMed · Cited by 200
Deregulation of caspase 8 and 10 expression in pediatric tumors and cell lines.
Harada, K., Toyooka, S., Shivapurkar, N., Maitra, A., Reddy, J., Matta, H., Miyajima, K., Timmons, C. F., Tomlinson, G. E., Mastrangelo, D., et al. (2002) · PubMed · Cited by 193
Chemosensitivity of solid tumor cells in vitro is related to activation of the CD95 system
Fulda, S., Łoś, M., Friesen, C., & Debatin, K. (1998) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19980330)76:1<105::aid-ijc17>3.0.co;2-b · Cited by 182
Self-citationMice Defective in Two Apoptosis Pathways in the Myeloid Lineage Develop Acute Myeloblastic Leukemia
Traver, D., Akashi, K., Weissman, I. L., & Lagasse, E. (1998) · Immunity · doi:10.1016/s1074-7613(00)80587-7 · Cited by 173
Proapoptotic BID is required for myeloid homeostasis and tumor suppression
Zinkel, S. S., Ong, C. C., Ferguson, D. O., Iwasaki, H., Akashi, K., Bronson, R. T., Kutok, J. L., Alt, F. W., & Korsmeyer, S. J. (2003) · Genes & Development · doi:10.1101/gad.1045603 · Cited by 169
Tamm, I., Richter, S., Oltersdorf, D., Creutzig, U., Harbott, J., Scholz, F., Karawajew, L., Ludwig, W.-D., & Wuchter, C. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0642 · Cited by 165
van Noesel, M. M., van Bezouw, S., Salomons, G. S., Voûte, P. A., Pieters, R., Baylin, S. B., Herman, J. G., & Versteeg, R. (2002) · PubMed · Cited by 165
Alterations of the DR5/TRAIL receptor 2 gene in non-small cell lung cancers.
Lee, S. H., Shin, M. S., Kim, H. S., Lee, H. K., Park, W. S., Kim, S. Y., Lee, J. H., Han, S. Y., Park, J. Y., Oh, R. R., et al. (1999) · PubMed · Cited by 160
Dysregulation of apoptosis genes in hematopoietic malignancies
Kitada, S., Pedersen, I. M., Schimmer, A. D., & Reed, J. C. (2002) · Oncogene · doi:10.1038/sj.onc.1205327 · Cited by 160
Reffey, S. B., Würthner, J., Parks, W. T., Roberts, A. B., & Duckett, C. S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100331200 · Cited by 153
Sheikh, M. S., Huang, Y., Fernández‐Salas, E., El‐Deiry, W. S., Friess, H., Amundson, S. A., Yin, J., Meltzer, S. J., Holbrook, N. J., & Fornace, A. J. (1999) · Oncogene · doi:10.1038/sj.onc.1202763 · Cited by 150
Fisher, M. J., Virmani, A. K., Wu, L., Aplenc, R., Harper, J. C., Powell, S. M., Rebbeck, T. R., Sidransky, D., Gazdar, A. F., & El‐Deiry, W. S. (2001) · PubMed · Cited by 143
Carter, B. Z., Kornblau, S. M., Tsao, T., Wang, R., Schober, W. D., Milella, M., Sung, H., Reed, J. C., & Andreeff, M. (2003) · Blood · doi:10.1182/blood-2003-03-0960 · Cited by 141
xIAP Induces Cell-Cycle Arrest and Activates Nuclear Factor-κB
Levkau, B., Garton, K. J., Ferri, N., Kloke, K., Nofer, J., Baba, H. A., Raines, E. W., & BREITHARDT, G. E. (2001) · Circulation Research · doi:10.1161/01.res.88.3.282 · Cited by 137
Fas Gene Mutation in the Progression of Adult T Cell Leukemia
Maeda, T., Yamada, Y., Moriuchi, R., Sugahara, K., Tsuruda, K., Joh, T., Atogami, S., Tsukasaki, K., Tomonaga, M., & Kamihira, S. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.7.1063 · Cited by 133
Ferreira, C. G., van der Valk, P., Span, S. W., Ludwig, I., Smit, E. F., Kruyt, F. A. E., Pinedo, H. M., van Tinteren, H., & Giaccone, G. (2001) · PubMed · Cited by 126
Pingoud-Meier, C., Lang, D., Janss, A. J., RORKE, L. B., Phillips∥, P. C., Shalaby, T., & Grotzer, M. A. (2003) · PubMed · Cited by 120
Cellular FLICE-inhibitory protein: an attractive therapeutic target?
Micheau, O. (2003) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.7.4.559 · Cited by 111
The death effector domain protein family
Barnhart, B. C., Lee, J. C., Alappat, E. C., & Peter, M. E. (2003) · Oncogene · doi:10.1038/sj.onc.1207103 · Cited by 105
Role of DNA methylation in the suppression of Apaf-1 protein in human leukaemia
Fu, W., Bertoni, F., Kelsey, S. M., McElwaine, S., Cotter, F. E., Newland, A. C., & Jia, L. (2003) · Oncogene · doi:10.1038/sj.onc.1206147 · Cited by 101
Ramp, U., Krieg, T. M., Çalışkan, E., Mahotka, C., Ebert, T., Willers, R., Gabbert, H. E., & Gerharz, C. D. (2004) · Human Pathology · doi:10.1016/j.humpath.2004.03.011 · Cited by 100
Uncoupling of the Signaling and Caspase-inhibitory Properties of X-linked Inhibitor of Apoptosis
Lewis, J., Burstein, E., Reffey, S. B., Bratton, S. B., Roberts, A. B., & Duckett, C. S. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m312891200 · Cited by 100
Peták, I., Danam, R. P., Tillman, D. M., Vernes, R., Howell, S. R., Berczi, L., Kopper, L., Brent, T. P., & Houghton, J. A. (2003) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401132 · Cited by 91
Varfolomeev, E. E., Wayson, S. M., Dixit, V. M., Fairbrother, W. J., & Vucic, D. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m605116200 · Cited by 89
Somatic mutations in the death domain of theFas (Apo-1/CD95) gene in gastric cancer
Park, W. S., Oh, R. R., Kim, Y. S., Park, J. Y., Lee, S. H., Shin, M. S., Kim, S. Y., Kim, P. J., Lee, H. K., Yoo, N. J., et al. (2001) · The Journal of Pathology · Cited by 65
Mohr, A., Zwacka, R. M., Jármy, G., et al. (2005) · Oncogene · doi:10.1038/sj.onc.1208432 · Cited by 59
Frequent LOH at Chromosome 12q22‐23 and Apaf‐1 Inactivation in Glioblastoma
Watanabe, T., Hirota, Y., Arakawa, Y., Fujisawa, H., Tachibana, O., Hasegawa, M., Yamashita, J., & Hayashi, Y. (2003) · Brain Pathology · doi:10.1111/j.1750-3639.2003.tb00474.x · Cited by 55
Dechant, M. J., Fellenberg, J., Scheuerpflug, C. G., Ewerbeck, V., & Debatin, K. (2004) · International Journal of Cancer · doi:10.1002/ijc.20008 · Cited by 55
Plenchette, S., Cheung, H. H., Fong, W. G., LaCasse, E. C., & Korneluk, R. G. (2007) · PubMed · Cited by 50
Expression of C‐IAP1, C‐IAP2 and SURVIVIN discriminates different types of lymphoid malignancies
de Graaf, A. O., Han van Krieken, J., Tönnissen, E., Wissink, W., van de Locht, L., Overes, I., Dolstra, H., de Witte, T., van der Reijden, B. A., & Jansen, J. H. (2005) · British Journal of Haematology · doi:10.1111/j.1365-2141.2005.05690.x · Cited by 42
Targeting Inhibitor of Apoptosis Proteins (IAPs) for Cancer Therapy
Fulda, S. (2008) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/187152008784533107 · Cited by 41
Self-citationMiller, M. A., Karaçay, B., Zhu, X., et al. (2005) · APOPTOSIS · doi:10.1007/s10495-005-3258-0 · Cited by 39
Mutation analysis and mRNA expression of trail‐receptors in human breast cancer
Seitz, S., Wassmuth, P., Fischer, J., Nothnagel, A., Jandrig, B., Schlag, P. M., & Scherneck, S. (2002) · International Journal of Cancer · doi:10.1002/ijc.10694 · Cited by 36
Wang, H. (2007) · World Journal of Gastroenterology · doi:10.3748/wjg.v13.i38.5060 · Cited by 21
Silencing of APAF‐1 in B‐CLL results in poor prognosis in the case of concomitant p53 mutation
Sturm, I., Bosanquet, A. G., Radetzki, S., Hummel, M., Dörken, B., & Daniel, P. T. (2005) · International Journal of Cancer · doi:10.1002/ijc.21535 · Cited by 19
Cited by
Targeting apoptosis in cancer therapy
Carneiro, B. A., & El-Deiry, W. S. (2020) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-020-0341-y · Cited by 2,542
Targeting mitochondria for cancer therapy
Fulda, S., Galluzzi, L., & Kroemer, G. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3137 · Cited by 1,629
Self-citationApoptosis and Molecular Targeting Therapy in Cancer
Hassan, M., Watari, H., AbuAlmaaty, A., Ohba, Y., & Sakuragi, N. (2014) · BioMed Research International · doi:10.1155/2014/150845 · Cited by 1,121
RetractedChondrocyte Apoptosis in the Pathogenesis of Osteoarthritis
Hwang, H., & Kim, H. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms161125943 · Cited by 886
Targeting IAP proteins for therapeutic intervention in cancer
Fulda, S., & Vucic, D. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3627 · Cited by 837
Self-citation
Metadata
- Authors
- Fulda, S.
- Venue
- International Journal of Cancer
- Publisher
- Wiley
- Published
- 2008-11-11
- Volume
- 124
- Issue
- 3
- Pages
- 511-515
- ISSN
- 0020-7136 (ISSN-L)
- 1097-0215
- OpenAlex
- W2065177893
- Cited by
- 615
- References
- 89
- FWCI
- 8.19
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.